- Consolidated Q3 revenue of $44.6 million
- Consolidated Q3 GAAP net loss of $3.2 million and non-GAAP net loss of $1.6 million
- Anticipate Q4 revenue of $41 to $45 million
ALBUQUERQUE, N.M., Aug. 7, 2014 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq:EMKR), a leading provider of compound semiconductor-based components, subsystems, and systems for the fiber optics and space solar power markets, today announced its financial results for its fiscal third quarter ended June 30, 2014.
Financial Highlights - Third Quarter Ended June 30, 2014
|
Financial Highlights |
For the Three Months Ended | ||||||||
| (in thousands) | 6/30/2014 | 3/31/2014 | 6/30/2013 | ||||||
| Fiber | Solar | Consolidated | Fiber | Solar | Consolidated | Fiber | Solar | Consolidated | |
| Revenue | $ 26,172 | $ 18,410 | $ 44,582 | $ 23,620 | $ 18,627 | $ 42,247 | $ 21,560 | $ 11,913 | $ 33,473 |
| Gross Profit | $ 4,288 | $ 5,105 | $ 9,393 | $ 1,933 | $ 4,933 | $ 6,866 | $ 638 | $ 3,406 | $ 4,044 |
| Operating (loss) income | $ (5,092) | $ 1,961 | $ (3,131) | $ (7,320) | $ 2,071 | $ (5,249) | $ (8,998) | $ 1,329 | $ (7,669) |
Financial Statement Highlights for the third quarter of fiscal 2014:
- Consolidated revenue was $44.6 million, representing a 5.5% increase from the immediate preceding quarter
- Fiber Optics revenues increased 10.8% over the immediate preceding quarter to $26.2 million, and Photovoltaics revenue decreased 1.2% to $18.4 million over the immediate preceding quarter
- Consolidated gross margin was 21.1%, an increase from the 16.3% gross margin reported in the immediate preceding quarter
- On a segment basis, Fiber Optics gross margin increased to 16.4% from the 8.2% gross margin reported in the immediate preceding quarter and Photovoltaics gross margin increased to 27.7% from the 26.5% gross margin reported in the immediate preceding quarter.
- Consolidated operating loss was $3.1 million, a $2.1 million improvement when compared to the immediate preceding quarter
- Consolidated net loss was $3.2 million, a $2.2 million improvement when compared to the immediate preceding quarter
- Consolidated net loss per share was $0.10 compared to a net loss per share of $0.18 in the immediate preceding quarter
- Non-GAAP net loss was $1.6 million, or $0.05 per share, an improvement of approximately $1.0 million, or $0.03 per share, over the immediate preceding quarter
- Order backlog for our Photovoltaics segment totaled $70.5 million as of June 30, 2014, representing a 37.2% increase from $51.4 million reported as of March 31, 2014
- Cash and cash equivalents stayed relatively flat at $18.2 million at the end of the third quarter
Business Outlook
On a consolidated basis, we expect revenue for our fourth quarter ended September 30, 2014 to be in the range of $41 to $45 million with an increase in Fiber revenue and a decrease in Photovoltaics revenue.
Conference Call
We will discuss our financial results today at 4:30 p.m. ET. The call will be webcast via the Company's website at http://www.emcore.com. Please go to the site beforehand to download any necessary software. A webcast will be available for replay beginning August 7, 2014 following the conclusion of the call on the Company's website.
About EMCORE
EMCORE Corporation offers a broad portfolio of compound semiconductor-based products for the fiber optics and space solar power markets. EMCORE's Fiber Optics business segment provides optical components, subsystems and systems for high-speed telecommunications, Cable Television (CATV) and Fiber-To-The-Premise (FTTP) networks, as well as products for satellite communications, video transport and specialty photonics technologies for defense and homeland security applications. EMCORE's Solar Photovoltaics business segment provides products for space power applications including high-efficiency multi-junction solar cells, Covered Interconnect Cells (CICs) and complete satellite solar panels. For further information about EMCORE, visit http://www.emcore.com.
Use of Non-GAAP Financial Measures
We provide a non-GAAP net loss disclosure as a supplemental measure to U.S. GAAP regarding our operational performance. This financial measure excludes the impact of certain items; therefore, it has not been calculated in accordance with U.S. GAAP.
We believe that this additional non-GAAP financial measure is useful to investors in assessing our operating performance. We also use this financial measure internally to evaluate our operating performance and for planning and forecasting of future periods. In addition, financial analysts that follow us may focus on and publish both historical results and future projections based on our non-GAAP financial measure. We also believe that it is in the best interest of our investors to provide this non-GAAP information.
While we believe that this non-GAAP financial measure provides useful supplemental information to investors, there are limitations associated with the use of this non-GAAP financial measure. Our non-GAAP financial measure may not be reported by all of our competitors and it may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using this non-GAAP financial measure as a supplement to U.S. GAAP and by providing a reconciliation of our non-GAAP financial measure to its most comparable U.S. GAAP financial measure.
Non-GAAP financial measures are not in accordance with or an alternative for U.S. GAAP. Our non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable U.S. GAAP financial measures and it should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP.
Forward-Looking Statements
The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, projections about our future results included in our Exchange Act reports, statements about our plans, strategies, business prospects, changes and trends in our business and the markets in which we operate.
These forward-looking statements may be identified by the use of terms and phrases such as "anticipates", "believes", "can", "could", "estimates", "expects", "forecasts", "intends", "may", "plans", "projects", "targets", "will", and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, enhancements or technologies, sales levels, expense levels and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) the rapidly evolving markets for the Company's products and uncertainty regarding the development of these markets; (b) the Company's historical dependence on sales to a limited number of customers and fluctuations in the mix of products and customers in any period; (c) delays and other difficulties in commercializing new products; (d) the failure of new products: (i) to perform as expected without material defects, (ii) to be manufactured at acceptable volumes, yields, and cost, (iii) to be qualified and accepted by our customers, and, (iv) to successfully compete with products offered by our competitors; (e) we may not be successful in undertaking the steps currently planned in order to increase our liquidity; (f) uncertainties concerning the availability and cost of commodity materials and specialized product components that we do not make internally; (g) actions by competitors; and (h) other risks and uncertainties described in our filings with the Securities and Exchange Commission ("SEC").
Neither management nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the SEC that are available on the SEC's web site located at www.sec.gov, including the sections entitled "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Certain information included in this press release may supersede or supplement forward-looking statements in our other Exchange Act reports filed with the SEC. We assume no obligation to update any forward-looking statement to conform such statements to actual results or to changes in our expectations, except as required by applicable law or regulation.
| EMCORE CORPORATION | |||||
| Condensed Consolidated Statements of Operations | |||||
| (in thousands, except per share data) | |||||
| (unaudited) | |||||
|
For the Three Months Ended |
For the Nine Months Ended |
||||
|
June 30, 2014 |
March 31, 2014 |
June 30, 2013 |
June 30, 2014 |
June 30, 2013 |
|
| Revenue | $ 44,582 | $ 42,247 | $ 33,473 | $ 131,040 | $ 125,056 |
| Cost of revenue | 35,189 | 35,381 | 29,429 | 104,646 | 102,231 |
| Gross profit | 9,393 | 6,866 | 4,044 | 26,394 | 22,825 |
| Operating expense (income): | |||||
| Selling, general, and administrative | 7,843 | 6,911 | 7,039 | 22,726 | 20,714 |
| Research and development | 4,681 | 5,204 | 4,674 | 14,288 | 14,176 |
| Flood-related insurance proceeds | — | — | — | — | (19,000) |
| Gain on sale of assets | — | — | — | — | (413) |
| Total operating expense | 12,524 | 12,115 | 11,713 | 37,014 | 15,477 |
| Operating (loss) income | (3,131) | (5,249) | (7,669) | (10,620) | 7,348 |
| Other income (expense): | |||||
| Interest expense, net | (134) | (117) | (185) | (377) | (609) |
| Foreign exchange gain (loss) | 5 | (90) | 181 | 15 | 261 |
| Gain on sale of investment | — | 17 | — | 307 | — |
| Change in fair value of financial instruments | 110 | 7 | 373 | 39 | 343 |
| Other expense | — | — | 17 | — | 17 |
| Total other (expense) income | (19) | (183) | 386 | (16) | 12 |
| (Loss) income before income tax expense | (3,150) | (5,432) | (7,283) | (10,636) | 7,360 |
| Income tax expense | — | — | — | — | (120) |
| Net (loss) income | $ (3,150) | $ (5,432) | $ (7,283) | $ (10,636) | $ 7,240 |
| Per share data: | |||||
| Net (loss) income per basic share | $ (0.10) | $ (0.18) | $ (0.27) | $ (0.35) | $ 0.27 |
| Net (loss) income per diluted share | $ (0.10) | $ (0.18) | $ (0.27) | $ (0.35) | $ 0.27 |
| Weighted-average number of basic shares outstanding | 30,656 | 30,392 | 26,609 | 30,327 | 26,320 |
| Weighted-average number of diluted shares outstanding | 30,656 | 30,392 | 26,609 | 30,327 | 26,620 |
| EMCORE CORPORATION | ||
| Condensed Consolidated Balance Sheets | ||
| (in thousands) | ||
| (unaudited) | ||
| As of | As of | |
| June 30, | September 30, | |
| 2014 | 2013 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 18,165 | $ 16,104 |
| Restricted cash | 806 | 815 |
| Accounts receivable, net | 43,196 | 41,826 |
| Inventory | 27,549 | 32,115 |
| Prepaid expenses and other current assets | 7,633 | 9,437 |
| Total current assets | 97,349 | 100,297 |
| Property, plant, and equipment, net | 46,048 | 49,744 |
| Goodwill | 20,384 | 20,384 |
| Other intangible assets, net | 1,396 | 2,159 |
| Other non-current assets, net | 835 | 1,130 |
| Total assets | $ 166,012 | $ 173,714 |
| LIABILITIES and SHAREHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Borrowings from credit facility | $ 20,937 | $ 21,706 |
| Accounts payable | 21,185 | 19,643 |
| Deferred gain associated with sale of assets | 3,400 | — |
| Warrant liability | 116 | 155 |
| Accrued expenses and other current liabilities | 19,846 | 21,597 |
| Total current liabilities | 65,484 | 63,101 |
| Asset retirement obligations | 5,209 | 5,053 |
| Deferred gain associated with sale of assets | — | 3,400 |
| Other long-term liabilities | 806 | 981 |
| Total liabilities | 71,499 | 72,535 |
| Shareholders' equity: | ||
| Common stock | 753,236 | 749,266 |
| Treasury stock | (2,071) | (2,071) |
| Accumulated other comprehensive income | 1,623 | 1,623 |
| Accumulated deficit | (658,275) | (647,639) |
| Total shareholders' equity | 94,513 | 101,179 |
| Total liabilities and shareholders' equity | $ 166,012 | $ 173,714 |
We have provided a reconciliation of our non-GAAP net (loss) income financial measure to its most directly comparable U.S. GAAP financial measure as indicated in the table below:
| EMCORE Corporation | |||||
| Non-GAAP Net Loss | |||||
| (in thousands, except per share data) | |||||
| (unaudited) | |||||
|
For the Three Months Ended |
For the Nine Months Ended |
||||
|
June 30, 2014 |
March 31, 2014 |
June 30, 2013 |
June 30, 2014 |
June 30, 2013 |
|
| Net (loss) income - US GAAP | $ (3,150) | $ (5,432) | $ (7,283) | $ (10,636) | $ 7,240 |
| Adjustments: | |||||
| Amortization expense | 254 | 254 | 317 | 762 | 952 |
| Stock-based compensation expense | 1,180 | 1,104 | 1,152 | 3,419 | 3,285 |
| Asset retirement obligations - accretion expense | 52 | 52 | 53 | 156 | 161 |
| Specific severance and restructuring charges | 179 | 358 | 241 | 991 | 422 |
| Flood-related insurance proceeds | — | — | — | — | (19,000) |
| Gain on sale of assets | — | — | — | — | (358) |
| Specific warranty charges | — | 1,045 | — | 1,045 | 1,425 |
| Foreign exchange (gain) loss | (5) | 90 | (181) | (15) | (261) |
| Gain on sale of investment | — | (17) | — | (307) | — |
| Change in fair value of financial instruments | (110) | (7) | (373) | (39) | (343) |
| Income tax expense | — | — | — | — | 120 |
| Total adjustments | 1,550 | 2,879 | 1,209 | 6,012 | (13,597) |
| Net loss - Non-GAAP | $ (1,600) | $ (2,553) | $ (6,074) | $ (4,624) | $ (6,357) |
| Net loss - Non-GAAP per basic share | $ (0.05) | $ (0.08) | $ (0.23) | $ (0.15) | $ (0.24) |
| Net loss - Non-GAAP per diluted share | $ (0.05) | $ (0.08) | $ (0.23) | $ (0.15) | $ (0.24) |
| Weighted average number of basic shares outstanding | 30,656 | 30,392 | 26,609 | 30,327 | 26,320 |
| Weighted average number of diluted shares outstanding | 30,656 | 30,392 | 26,609 | 30,327 | 26,320 |
Stock-based compensation expense
The effect of recording stock-based compensation expense was as follows:
| Stock-based Compensation Expense |
For the Three Months Ended |
For the Nine Months Ended |
|||
| (in thousands) |
June 30, 2014 |
March 31, 2014 |
June 30, 2013 |
June 30, 2014 |
June 30, 2013 |
| Cost of revenue | $ 254 | $ 214 | $ 311 | $ 685 | $ 916 |
| Selling, general, and administrative | 607 | 579 | 485 | 1,827 | 1,326 |
| Research and development | 319 | 311 | 356 | 907 | 1,043 |
| Total stock-based compensation expense | $ 1,180 | $ 1,104 | $ 1,152 | $ 3,419 | $ 3,285 |